• Home
  • Venus Pharma GmbH

Venus Pharma GmbH

  • Venus Fulvestrant
  • Venus Remedies Secures Coveted UNICEF Approval for Global Impact
  • Market Authorization
  • Accreditations & Approvals
  • Meropenem 500mg, 1000mg and 2000mg
  • Meropenem
  • Venus is an Indian research-driven pharmaceutical company dedicated to developin
  • Venus Market Authorization & Global Presence
  • Uncover the future of healthcare with Venus Remedies & Venus Pharma GmbH at CPhI
  • Women in Pharma
  • Venus is proud to announce the Marketing Authorization of its products across multiple countries, marking another milestone in our global journey. In the Philippines, Bendamustine and Paclitaxel have been approved.
  • Exciting news from Venus Remedies! Our Docetaxel 20mg, 80mg, and 160mg have received new marketing authorization in Slovenia, enabling us to offer vital cancer treatments to patients in the region.
  • This new authorization reinforces our mission to contribute to global healthcare by providing life-changing treatments to patients worldwide
  • Venus Remedies has achieved Marketing Authorization for key cancer treatment products across multiple countries. Our Paclitaxel 9300mg/50ml) is now approved in the Philippines, while Paclitaxel (100mg/16.7ml), Etoposide (100mg/5ml), and Bleomycin (15U)
  • Join our Executive Leadership Team to gain firsthand insights from our visionary leaders as we unveil our most recent innovations in medical technology and solutions.
  • venusremedieslimited's profile picture Venus Remedies continues to make strides in global healthcare. The company is excited to announce the acquisition of new marketing authorizations for Meropenem (500mg and 1000mg) in Serbia,
  • Accrediation & Awards
  • Venus Remedies: Pioneering the Future of Global Healthcare
  • https://venusremedies.com/cphi
  • https://venusremedies.com/cphi
  • https://venusremedies.com/cphi
  • Venus Remedies clinches dual tender from UNICEF & PAHO to enhance healthcare access
  • Venus product List
  • Venus product List
  • GALLERY
  • Conference
  • CPHI 2022
  • GALLERY
  • GALLERY
  • Venus Remedies
  • Meropenem: The Powerful Antibacterial Solution for Effective Treatment
  • Workshops
  • CPHI 2022
  • Conferences
About Venus Pharma GmbH

Venus Remedies Limited/Venus Pharma GmbH, globally recognized for their unwavering commitment to quality and innovation, proudly holds EU-GMP certification in injectable manufacturing, a testament to their world-class manufacturing standards. With a vast global footprint spanning 70 countries, our reputation is underpinned by 20+ distinguished acc...

Read more Show less
Certifications
  • CE
    CE
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • DE
  • 2019
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Clinical Research
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Regulatory Affairs
View company profile
Contact info
Show contact info Hide contact info
Meet us at

CPHI Frankfurt 2025

Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025
View Exhibitor Profile

Products from Venus Pharma GmbH (6)

  • ANTIBIOTIC INJECTABLES Meropenem(FOR CRITICAL CARE)

    Product ANTIBIOTIC INJECTABLES Meropenem(FOR CRITICAL CARE)

    CEFEPIME FOR INJECTION | CEFTRIAXONE | CEFTAZIDIME FOR INJECTION | CEFOPERAZONE + SULBACTAM FOR INJECTION | CEFUROXIME FOR INJECTION | CEFOTAXIME FOR INJECTION | CEFTAZIDIME AVIBACTAM FOR INJECTION | CEFTRIAXONE SULBACTAM FOR INJECTION | ELORES: CEFTRIAXONE, SULBACTAM & EDTA FOR INJECTION | AZTREONAM F...
  • ONCOLOGY LIQUID INJECTABLES

    Product ONCOLOGY LIQUID INJECTABLES

    CARBOPLATIN | CISPLATIN | CYTARABINE LIQUID | DOCETAXEL WITH SOLVENT | DOCETAXEL (CTD) SINGLE VIAL | DOXORUBICIN | EPIRUBICINE | ETOPOSIDE  | IRINOTECAN | LEUCOVORIN CALCIUM | METHOTREXATE | OXALIPLATIN | PLERIXAFOR | PACLITAXEL  | VINCRISTINE | 5-FLOUROURACIL | FULVESTRANT
  • ONCOLOGY LYOPHILIZED INJECTABLES

    Product ONCOLOGY LYOPHILIZED INJECTABLES

    AZACITIDINE | BENDAMUSTINE  | BLEOMYCIN | BORTEZOMIB | CYTARABINE  | DACARBAZINE | EPIRUBICIN  | GEMCITABINE | PEMETREXED | TOPOTECAN | ZOLENDRONIC ACID
  • PREFILLED SYRINGE (ENOXOPARIN) BIOSIMILAR

    Product PREFILLED SYRINGE (ENOXOPARIN) BIOSIMILAR

    ENOXAPARIN PFS 100MG/ML

  • Product List for Venus Remedies Limied-CPHI 2024

    Product Product List for Venus Remedies Limied-CPHI 2024

    At VENUS REMEDIES LIMITED, we approach business partnerships with a strategic mindset, fostering collaboration that is not only successful in the short term but also sustainable and mutually beneficial in the long run.
  • OTHER INJECTABLES

    Product OTHER INJECTABLES

    REMDESIVIR FOR INJECTION | ACECLOFENAC | CISATRACURIUM BESYLATE | CITICOLINE | DEXMETOMIDINE | L-ORNITHINE L-ASPARTATE | MIDAZOLAM INJ | N-ACETYLCYSTEINE | SUGAMMADEX| PARACETAMOL

Venus Pharma GmbH Resources (8)